Oncolytic Virotherapy Plus PD-1 Inhibitor and Lenvatinib for Patients With Advanced Pancreatic Cancer
Clinical trial NCT05303090 · COMPLETED
Trial details
- NCT number
- NCT05303090
- Sponsor
- Fudan University
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-31
- Primary completion
- 2024-04-23
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.